Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Research use via CTN with HREC approval is theoretically available but no Australian trials are registered on ANZCTR for these compounds as of early 2026
Contexto comparativo vs TB-500 (Timosina 4 fragmento 17-23) : Mecanismo: TB-500 acta principalmente sobre actina-G y migracin celular
The control group comprised 61 patients and the remission group consisted of 35 patients who achieved remission
Check your coverage or estimate the cost of your visit if youre uninsured or prefer to pay out-of-pocket
US$ 25.81
US$ 26.17
US$ 21.16
US$ 23.76
US$ 22.58
US$ 27.33
US$ 22.07
US$ 27.22
US$ 26.76
